From Mutation to Management: Risk Stratification, the Power of JAK Inhibition, and the Pharmacist’s Role

Source: Pharmacy Times articles

Explore the role of JAK inhibitors in myelofibrosis treatment, focusing on optimizing dosages and managing adverse effects for better patient outcomes.
Read More